Medtronic plc.

Open: 83.54 Close: 83.6 Change: 0.06

12 things an AI found about Medtronic plc. Stock that you should know before investing.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, medical, MDT, Medtronics, stock, device, quarter, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Ireland-based Medtronic (NYSE: MDT) reported Q4 FY23 sales of $8.54 billion, up 5.6% Y/Y as reported and organic, ahead of expectations, beating the consensus of $8.25 billion. Shares of the medical device maker were down by 5%.

Today's News

Medtronic (www.medtronic.com) is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world. The medical device makers fourth-quarter results were down by 5% on heavy volume. Medtronic names new chief technology and innovation officer. Washington most recently served as VP and GM of consumer robotics at Amazon. Medtronic plc (NYSE:MDT) develops and manufactures device-based medical therapies. Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of$0.05 per share. The share price of MDT is 83.60 USD today. Medtronic PLC agreed to acquire Eoflow Co. to boost diabetes business May 25, 2023. The medical technology corporation focuses on developing device-based medical therapies and services. Recently, large investors like Vanguard Group Inc., BlackRock Inc., State Street Corp, Bank of New York. Medtronic named Ken Washington, Ph.D., as Chief Technology and Innovation Officer. CEO Geoff Martha to speak at Goldman Sachs global healthcare conference. Medtronic trades on the NYSE under the ticker symbol MDT. The total value of Medtronics stock (market capitalization) is $111.22B. If you had invested in Medtronics stock at $26.25 in 1997, your return over the last 25 years would have been 218.48%. Medtronic PLC stock underperforms Monday when compared to competitors - marketwatch.com. The S&P 500 Index SPX, +0.24% fell 0.20% to 4,273.79 and Dow Jones Industrial Average DJIA falling 0.59% to 33,562.86. Medtronic PLC dividend history is presented both in graphical/chart form, and as a MDT dividend history data table. The Federal Circuit has refused to revive medical device company Medtronics challenge to a group of catheter patents. Ireland-based Medtronic (NYSE: MDT), a major player in the medical device industry, is one such company. There are a few key trends that could drive future revenue growth. Ireland-based Medtronic (NYSE: MDT) reported Q4 FY23 sales of $8.54 billion, up 5.6% Y/Y as reported and organic, ahead of expectations, beating the consensus of $8.25 billion. Shares of the medical device maker were down by 5% on heavy volume as of Tuesday morning. Medtronic recorded an earnings and revenue beat in the fiscal fourth quarter. Medtronics largest businesses — Cardiac Rhythm, Surgical and Spine plus ENT — laid a strong foundation for the companys growth in the quarter. The CVG Remote Sales rep sells Medtron products and retains end-user patients. 20 years of reliable Medtronic stock forecast. 20 analysts predict that Medtronics share price will fall in the coming year, reaching $86.00. 20 years ago. 20-year-old stock forecast. Medtronic to invest Rs.3,000 crore in engineering and innovation centre in Hyderabad. The investment builds on the initial investment of $160M in MEIC that was announced in 2020 and aims at expanding the companies footprint in India.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, medical, MDT, Medtronics, stock, device, quarter, and the most common words in the summary are: medtronic, stock, mdt, market, plc, price, job, . One of the sentences in the summary was: Ireland-based Medtronic (NYSE: MDT) reported Q4 FY23 sales of $8.54 billion, up 5.6% Y/Y as reported and organic, ahead of expectations, beating the consensus of $8.25 billion. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #mdt #market #plc #price #job.